IFN signaling is strongly activated in COVID-19 as part of the antiviral response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with IFN alpha and gamma response signatures being the top gene sets enriched in the whole blood transcriptome of hospitalized patients with COVID-19 (22). This evidence concerns the gene IFNA1 and COVID-19.